Cargando…
芦可替尼联合泼尼松、沙利度胺和达那唑治疗骨髓纤维化的探索性研究
OBJECTIVE: To evaluate the efficacy and tolerability of ruxolitinib combined with prednisone, thalidomide and danazol for treatment of in myelofibrosis (MF). METHODS: Patients of MF according to the WHO 2016 criteria, received ruxolitinib (RUX) combined with prednisone, thalidomide and danazol (PTD)...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351690/ https://www.ncbi.nlm.nih.gov/pubmed/30704224 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.01.005 |